PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1089963
PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1089963
According to SPER Market Research, the Cell & Gene Therapy Manufacturing Services Market estimated to reach USD 20.68 billion by 2030 with a CAGR of 11.6%. The collaboration between pharmaceutical companies and CDMOs, rising prevalence of cancer and various targeted disease, rising pharmaceutical research & development, High investments by CDMOs in advanced technology; these factors act as the fuel to the escalation of the market.
Because of the outbreak of COVID-19, there is disruption of clinical trials due to the deferral of patient enrolment. Clinical trials such as; cardiovascular disease, respiratory disease, oncology, anti-infective, were the worst-hit in this time. This leads to the squeeze of production and research.
The key drivers to the escalation of the market are; towering prevalence of cancer and other target diseases, rising investments in pharmaceutical research & development, funding in advanced technologies by CDMOs, escalating partnerships and agreements among CDMOs and pharmaceutical companies.
The manufacturing of cell & gene therapy is costly; this might resist the expansion of market.
The demand for cell & gene therapies is escalating globally, the elevated number of cell & gene therapy clinical trials; give the impetus to the top player in this market.
There is chances of superfluous outcomes and threat of mutagenesis; are the challenges to this market.
Based on the Type, Global Cell & Gene Therapy Manufacturing Services Market is segment as; Cell Therapy {Allogeneic (Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Natural Killer Cells, Other Allogeneic Cells, T-cells), Autologous (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Natural Killer Cells, T-cells), Viral Vector (Adeno-associated Virus Vectors, Other Viral Vectors, Retroviral Vectors)}, Gene Therapy {Non-viral Vector, Oligonucleotides, Viral Vector (Retroviral Vectors, Adeno-associated Virus Vectors, Other Viral Vectors)}.
Based on the Indication, Global Cell & Gene Therapy Manufacturing Services Market is segment as; Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases, Oncology Diseases, Ophthalmology Diseases, Orthopaedic Diseases, Other Indications
Based on the Application, Global Cell & Gene Therapy Manufacturing Services Market is segment as; Clinical Manufacturing, Commercial Manufacturing.
Based on the End-Users, Global Cell & Gene Therapy Manufacturing Services Market is segment as; Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Other End Users.
North America owns the prime share of this market; this is due to the increasing prevalence of cancer, increasing research in stem cell and cancer in this region.